Trials / Conditions / Transfusional Hemosiderosis
Transfusional Hemosiderosis
5 registered clinical trials studyying Transfusional Hemosiderosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Treatment of Iron Overload Requiring Chelation Therapy NCT01927913 | Shire | Phase 2 |
| Completed | Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox NCT01394029 | Novartis Pharmaceuticals | — |
| Completed | Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to NCT00845871 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload NCT00600938 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis NCT00631163 | Novartis Pharmaceuticals | Phase 2 |